New scientific achievement
MerloBioEngineering is proud to announce the results of a successful collaboration involving 25 Italian hospitals, showcasing the power of multidisciplinary teamwork in modern healthcare.
This achievement results from the efforts of the Italian Complexity Group, a nationwide network of experts dedicated to addressing the increasing challenges of managing patients with complex rehabilitation needs and multiple comorbidities.
We already discussed our previous publications here.
Scientific publication
A recent scientific publication titled “The integration of the Italian Rehabilitation Complexity Scale in the assessment of patients admitted to different levels in public and private accredited settings and belonging to the main rehabilitative MDCs: a national experience” has been released.
This multicenter research examined data from over 2,800 patients admitted to specialized post-acute rehabilitation units and intensive rehabilitation centers. Its main goal was to assess how the Rehabilitation Complexity Scale–Extended v13 (RCS-E v13), alongside the Barthel Index and the Cumulative Illness Rating Scale, could enhance patient profiling across different levels of care.
You can read the full text here.
Improving patient stratification and care planning
The results of the study endorse using RCS-E v13 alongside the Barthel Index as an effective method for evaluating admission appropriateness, improving prognostic stratification, and aiding personalized care planning. These findings emphasize the significance of integrated assessment tools in refining rehabilitation strategies for complex patients.
Enhancing the management of patients with high clinical complexity and multiple comorbidities is a crucial area in both neurological and musculoskeletal rehabilitation. Developing and validating new tools is vital to ensure care pathways are both clinically effective and efficient, supporting sustainability within modern healthcare systems.
Collaboration and innovation
Participating in the Italian Complexity Group offers a vital platform for continuous exchange, scientific dialogue, and collaboration among top professionals throughout Italy. For MerloBioEngineering, this initiative serves as a significant opportunity to engage in conversations that reflect the company’s core values of innovation, integration, and clinical excellence.
Congratulations to all authors and contributors involved in this meaningful national effort!
